Survival and relative dose intensity of 5-fluorouracil, oxaliplatin and irinotecan in real-life treatment of metastatic colorectal cancer

Guardado en:
Detalles Bibliográficos
Autores principales: Ilfad Blazevic, Willy Vaillant, Maud Basso, Karine Salignon
Formato: article
Lenguaje:EN
Publicado: Termedia Publishing House 2020
Materias:
R
Acceso en línea:https://doaj.org/article/7445ee124c9c46e69adaadea408f5fc6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7445ee124c9c46e69adaadea408f5fc6
record_format dspace
spelling oai:doaj.org-article:7445ee124c9c46e69adaadea408f5fc62021-12-02T17:18:54ZSurvival and relative dose intensity of 5-fluorouracil, oxaliplatin and irinotecan in real-life treatment of metastatic colorectal cancer1428-25261897-430910.5114/wo.2020.100222https://doaj.org/article/7445ee124c9c46e69adaadea408f5fc62020-10-01T00:00:00Zhttps://www.termedia.pl/Survival-and-relative-dose-intensity-of-5-fluorouracil-oxaliplatin-and-irinotecan-in-real-life-treatment-of-metastatic-colorectal-cancer,3,42182,1,1.htmlhttps://doaj.org/toc/1428-2526https://doaj.org/toc/1897-4309Ilfad BlazevicWilly VaillantMaud BassoKarine SalignonTermedia Publishing Housearticlecolorectal cancer relative dose intensity chemotherapy survival real-life.MedicineRENContemporary Oncology, Vol 24, Iss 3, Pp 150-156 (2020)
institution DOAJ
collection DOAJ
language EN
topic colorectal cancer
relative dose intensity
chemotherapy
survival
real-life.
Medicine
R
spellingShingle colorectal cancer
relative dose intensity
chemotherapy
survival
real-life.
Medicine
R
Ilfad Blazevic
Willy Vaillant
Maud Basso
Karine Salignon
Survival and relative dose intensity of 5-fluorouracil, oxaliplatin and irinotecan in real-life treatment of metastatic colorectal cancer
format article
author Ilfad Blazevic
Willy Vaillant
Maud Basso
Karine Salignon
author_facet Ilfad Blazevic
Willy Vaillant
Maud Basso
Karine Salignon
author_sort Ilfad Blazevic
title Survival and relative dose intensity of 5-fluorouracil, oxaliplatin and irinotecan in real-life treatment of metastatic colorectal cancer
title_short Survival and relative dose intensity of 5-fluorouracil, oxaliplatin and irinotecan in real-life treatment of metastatic colorectal cancer
title_full Survival and relative dose intensity of 5-fluorouracil, oxaliplatin and irinotecan in real-life treatment of metastatic colorectal cancer
title_fullStr Survival and relative dose intensity of 5-fluorouracil, oxaliplatin and irinotecan in real-life treatment of metastatic colorectal cancer
title_full_unstemmed Survival and relative dose intensity of 5-fluorouracil, oxaliplatin and irinotecan in real-life treatment of metastatic colorectal cancer
title_sort survival and relative dose intensity of 5-fluorouracil, oxaliplatin and irinotecan in real-life treatment of metastatic colorectal cancer
publisher Termedia Publishing House
publishDate 2020
url https://doaj.org/article/7445ee124c9c46e69adaadea408f5fc6
work_keys_str_mv AT ilfadblazevic survivalandrelativedoseintensityof5fluorouraciloxaliplatinandirinotecaninreallifetreatmentofmetastaticcolorectalcancer
AT willyvaillant survivalandrelativedoseintensityof5fluorouraciloxaliplatinandirinotecaninreallifetreatmentofmetastaticcolorectalcancer
AT maudbasso survivalandrelativedoseintensityof5fluorouraciloxaliplatinandirinotecaninreallifetreatmentofmetastaticcolorectalcancer
AT karinesalignon survivalandrelativedoseintensityof5fluorouraciloxaliplatinandirinotecaninreallifetreatmentofmetastaticcolorectalcancer
_version_ 1718381093351063552